Sept 14 (Reuters) - Noxopharm Ltd (NOX) :
- ANNOUNCES RESULTS FROM NOVEL 'DUAL-CELL' THERAPY PANCREATIC CANCER STUDY
- MAJOR FINDINGS WERE THAT CRO-67 KILLED TUMOUR CELLS AS WELL AS BARRIER CELLS IN SAMPLES TAKEN FROM SIX PATIENTS
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.010(8.00%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $14.86K | 129.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 62035 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 5687 | 3 |
View Market Depth
| Last trade - 14.40pm 13/08/2025 (20 minute delay) ? |
| NOX (ASX) Chart |